DEA’s Proposed Telemedicine Rule: What It May Mean for Prescribing Controlled Substances via Telehealth
By Carrie Foote on March 6, 2025, with contributions from Michael Holcomb and Tara Sklar, JD, MPH
On January 17, 2025, the Drug Enforcement Administration (DEA) proposed a new telemedicine regulation, entitled Special Registrations for Telemedicine and Limited State Telemedicine Registrations, that impact healthcare practitioners, telemedicine platforms, and patients. Key elements of the proposed rule include the introduction of a three-tiered special registration system, new state registration requirements for prescribing controlled substances, increased reporting and recordkeeping obligations, and updated controls on Schedule II substances. This proposed rule, once finalized and effective, will require that providers practicing via telemedicine and telemedicine platforms update their workflows accordingly.
Read more »
Share this:    |